Bio-IT World April 23, 2021
Contributed Commentary by Said Ismail

Over the past 20 years, the field of genomics has undergone significant progress and transformation. We are at an exciting juncture in this field; however, there is more to be done to ensure more equitable access to technologies and support researchers around the world. The global fight against COVID-19 has highlighted the promise of genome sequencing, but its reach extends well beyond this pandemic. I believe the case for prioritizing global genomic research that can help all populations is clearer than ever before.

COVID-19 Demonstrated the Value of Genome Sequencing

As we have seen, the rapid spotting of new variants of COVID-19 using widespread viral genome sequencing has proven to be successful, especially in identifying new variants in places where...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Pharma / Biotech, Precision Medicine
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article